Artelo Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:ARTL

Comments

Artelo Biosciences Inc Earnings Estimates

ARTLNASDAQ

Trade with Public

$5.95

-0.56-8.60%

At close: Apr 10, 5:00 PM EST

$5.87

-0.08-1.34%

After Hours: Apr 10, 7:34 PM EST

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Artelo Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:ARTL

Artelo Biosciences (ARTL) is scheduled to report Q1 earnings on May 12, 2026. Analysts estimate EPS of $-1.57 and quarterly revenue of N/A.

In the most recent quarter (Q4), Artelo Biosciences reported EPS of $4.14, beating estimates of $-4.71 by 1.88%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Artelo Biosciences has averaged an EPS surprise of 2.65% and a revenue surprise of 0.00%.

Earnings Date

May 12

EPS Estimate

$-1.570

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Artelo Biosciences Earnings History

Analyze the earnings history of Artelo Biosciences using advanced sorting and filters.

Loading calendar...

Artelo Biosciences (ARTL) Earnings Per Share

The chart below shows Artelo Biosciences's reported EPS compared to analyst estimates over recent quarters.

Artelo Biosciences (ARTL) Revenue

The chart below shows Artelo Biosciences's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Artelo Biosciences (NASDAQ:ARTL) reporting earnings?

Artelo Biosciences (ARTL) is scheduled to report earnings on May 12, 2026. The last reported earnings were for reported on February 24, 2026 for Q4.

What were the latest earnings per share (EPS) for Artelo Biosciences (NASDAQ:ARTL)?

The Actual EPS was $4.14, which beat the estimate of $-4.71.

What were Artelo Biosciences’s (NASDAQ:ARTL) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

60 Degrees Pharmaceuticals Inc

NASDAQ:SXTP

$1.76

Addex Therapeutics Ltd

NASDAQ:ADXN

$6.38

-3.33%

Kiora Pharmaceuticals Inc

NASDAQ:KPRX

$2.37

-4.05%

InMed Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc

NASDAQ:SNOA

$2.28

Artelo Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:ARTL

Artelo Biosciences (ARTL) is scheduled to report Q1 earnings on May 12, 2026. Analysts estimate EPS of $-1.57 and quarterly revenue of N/A.

In the most recent quarter (Q4), Artelo Biosciences reported EPS of $4.14, beating estimates of $-4.71 by 1.88%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Artelo Biosciences has averaged an EPS surprise of 2.65% and a revenue surprise of 0.00%.

Earnings Date

May 12

EPS Estimate

$-1.570

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–